CJC-1295 with DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), specifically modified to enhance its pharmacokinetic properties. The “DAC” refers to a Drug Affinity Complex, a molecular modification that significantly extends the peptide’s half-life by enabling covalent binding to serum albumin.